Selective pharmacological inhibition of P300 displays a prominent tumor-suppressive effect.154 The expression of MITF can be a promising predictor of the therapeutic vulnerability to P300 inhibition155,156 (Fig. 5). The gene discussed is MITF; the disease is neoplasm.